Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

Karin Purshouse; John p Thomson; Mahéva Vallet; Lorna Alexander; Isaac Bonisteel; Maree Brennan; David a. Cameron; Jonine Figueroa; Elizabeth Furrie; Pamela Haig; Mattea Heck; Hugh Mccaughan; Paul Mitchell; Heather Mcvicars; Lorraine Primrose; Kate Templeton; Natalie Wilson; Peter s. Hall

doi:10.1200/JCO.2022.40.16_suppl.e18733

Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

Karin Purshouse, John p Thomson, Mahéva Vallet, Lorna Alexander, Isaac Bonisteel, Maree Brennan, David a. Cameron, Jonine Figueroa, Elizabeth Furrie, Pamela Haig, Mattea Heck, Hugh Mccaughan, Paul Mitchell, Heather Mcvicars, Lorraine Primrose, Kate Templeton, Natalie Wilson, Peter s. Hall

Research output: Other contribution

Original language	English
Edition	16_suppl
Volume	40
DOIs	https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733
Publication status	Published - 1 Jun 2022

Publication series

Name	Journal of Clinical Oncology
Publisher	American Society of Clinical Oncology
ISSN (Print)	0732-183X

Access to Document

10.1200/JCO.2022.40.16_suppl.e18733

https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.e18733

Cite this

Purshouse, K., Thomson, J. P., Vallet, M., Alexander, L., Bonisteel, I., Brennan, M., Cameron, D. A., Figueroa, J., Furrie, E., Haig, P., Heck, M., Mccaughan, H., Mitchell, P., Mcvicars, H., Primrose, L., Templeton, K., Wilson, N., & Hall, P. S. (2022, Jun 1). Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic. (16_suppl ed.) https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733

@misc{b13864af9bee4f93b3e626032dec07f4,

title = "Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.",

author = "Karin Purshouse and Thomson, {John p} and Mah{\'e}va Vallet and Lorna Alexander and Isaac Bonisteel and Maree Brennan and Cameron, {David a.} and Jonine Figueroa and Elizabeth Furrie and Pamela Haig and Mattea Heck and Hugh Mccaughan and Paul Mitchell and Heather Mcvicars and Lorraine Primrose and Kate Templeton and Natalie Wilson and Hall, {Peter s.}",

year = "2022",

month = jun,

day = "1",

doi = "10.1200/JCO.2022.40.16_suppl.e18733",

language = "English",

volume = "40",

series = "Journal of Clinical Oncology",

publisher = "American Society of Clinical Oncology",

edition = "16_suppl",

type = "Other",

}

Purshouse, K , Thomson, JP , Vallet, M, Alexander, L, Bonisteel, I, Brennan, M, Cameron, DA , Figueroa, J, Furrie, E, Haig, P, Heck, M, Mccaughan, H , Mitchell, P, Mcvicars, H, Primrose, L, Templeton, K, Wilson, N & Hall, PS 2022, Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.. https://doi.org/10.1200/JCO.2022.40.16_suppl.e18733

TY - GEN

T1 - Scottish COVID CAncer iMmunity Prevalence (SCCAMP): A longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemic.

AU - Purshouse, Karin

AU - Thomson, John p

AU - Vallet, Mahéva

AU - Alexander, Lorna

AU - Bonisteel, Isaac

AU - Brennan, Maree

AU - Cameron, David a.

AU - Figueroa, Jonine

AU - Furrie, Elizabeth

AU - Haig, Pamela

AU - Heck, Mattea

AU - Mccaughan, Hugh

AU - Mitchell, Paul

AU - Mcvicars, Heather

AU - Primrose, Lorraine

AU - Templeton, Kate

AU - Wilson, Natalie

AU - Hall, Peter s.

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1200/JCO.2022.40.16_suppl.e18733

DO - 10.1200/JCO.2022.40.16_suppl.e18733

M3 - Other contribution

VL - 40

T3 - Journal of Clinical Oncology

ER -